UBI Shanghai

Shanghai Shen Lian Biomedical is a China-based listed veterinary biologics company focused on the research, development, manufacturing, and commercialization of animal vaccines, diagnostic reagents, and emerging pet biologics. The company is best known for swine foot-and-mouth disease vaccines and has expanded into subunit, inactivated, synthetic peptide, diagnostic, and mRNA-based animal health products. It operates GMP manufacturing bases in Shanghai and Lanzhou and markets products for swine, ruminants, and companion animals. The company appears to be the entity referred to as "UBI Shanghai" in UBI group materials, where it is described as a UBI affiliate that commercialized swine foot-and-mouth disease vaccines in China. As of 2026, it is active, publicly traded on Shanghai's STAR Market, and remains primarily an animal-health rather than human-biopharma company.